Minerva Neurosciences, Inc. (NERV)

Every figure this model derived for NERV, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2024-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2022-12-31
cash 75,267,250 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 79,732,517 AssetsCurrent 2026-06-30
current liabilities 3,958,061 LiabilitiesCurrent 2026-06-30
equity -213,300,623 StockholdersEquity 2026-06-30
revenue 0 RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31
sbc 0 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up NERV on one particular measure came for.

RatioValue
current ratio20.14
current ratio reported20.14
dilution pct11.76

What to be careful about

What this model itself distrusts about NERV's figures. Written by the derivation as it ran, not added afterwards.